Current Status of Vaccine of Human Papillomavirus-positive Patients with Oropharyngeal Carcinoma

The oropharynx is amongst the most common sites of cancer in Indian male population. The human papillomavirus (HPV) infection causes approximately 5% of cancers worldwide. HPV-positive patients (12–16 HPV genotypes) with oropharyngeal carcinoma (OPC) of the tonsil and base of the tongue are increasi...

Full description

Saved in:
Bibliographic Details
Main Author: Mohan Bansal
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2024-01-01
Series:NMO Journal
Subjects:
Online Access:https://journals.lww.com/10.4103/JNMO.JNMO_23_24
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:The oropharynx is amongst the most common sites of cancer in Indian male population. The human papillomavirus (HPV) infection causes approximately 5% of cancers worldwide. HPV-positive patients (12–16 HPV genotypes) with oropharyngeal carcinoma (OPC) of the tonsil and base of the tongue are increasing significantly not only in India but also in the USA and some European countries. The abovementioned facts were the driving force to conduct this present study. The aims of the present were (1) To know the relationship between the HPV vaccination and the incidence of OPC in men and (2) Can pan-gender HPV vaccination reduce the incidence of HPV patients with OPC. The study reviewed the literature using MEDLINE/PubMed and Google Scholar. The English language articles having abstracts were included on 28 March 2024. The study investigated the effect of HPV vaccination on the incidence and prevalence of HPV-positive men with OPC in the last 3 years (January 2021 to December 2023). The current study observed HPV vaccination reducing the oral HPV positivity in men and indicating the decreased risk of developing HPV-positive patients with not only OPC but also other HPV-associated head-and-neck cancers. The study found that the introduction of pan-gender HPV vaccination can reduce the incidences of HPV-positive men with OPC. Therefore, HPV vaccination in pre-teens, early teens and young boys can prevent not only HPV-positive men with OPC but also other cancers of head-and-neck regions.
ISSN:2348-3806
2950-5933